Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Sharma, Ashish K ^a   Linden, Joel ^a   Kron, Irving L ^a   Laubach, Victor E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; MYELOPEROXIDASE; RANTES; TUMOR NECROSIS FACTOR ALPHA; ATL 313; PEROXIDASE; PIPERIDINE DERIVATIVE;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LEUKOCYTE; LUNG ALVEOLUS CELL; LUNG ARTERY PRESSURE; LUNG COMPLIANCE; LUNG EDEMA; LUNG FLUID; LUNG FUNCTION; LUNG INJURY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REPERFUSION INJURY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CAPILLARY PERMEABILITY; CYTOLOGY; DRUG POTENTIATION; GENETICS; LUNG; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CHEMOKINES; CYTOKINES; LUNG; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PEROXIDASE; PIPERIDINES; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY; RESPIRATORY FUNCTION TESTS;

EID: 70249093288     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-58     Document Type: Article

References (50)

1. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, Robbins MK, Kron IL. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002, 73:1041-1047. 10.1016/S0003-4975(01)03606-2, 11996238.
2. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003, 167:490-511. 10.1164/rccm.200207-670SO, 12588712.
3. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003, 22:1007-1018. 10.1183/09031936.03.00039103, 14680094.
4. Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, Kron IL, Laubach VE. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006, 291:L1018-1026. 10.1152/ajplung.00086.2006, 16861385.
5. Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2007, 293:L105-113. 10.1152/ajplung.00470.2006, 17416740.
6. Ross SD, Tribble CG, Gaughen JR, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 1999, 67:1428-1433. 10.1016/S0003-4975(99)00248-9, 10355425.
7. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997, 150:1773-1784. 1858208, 9137100.
8. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 1995, 58:713-718. 10.1006/jsre.1995.1112, 7791351.
9. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995, 110:4-13. 10.1016/S0022-5223(05)80003-0, 7609567.
10. Snell GI, Esmore DS, Williams TJ. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 1996, 109:874-878. 10.1378/chest.109.4.874, 8635363.
11. Mal H, Dehoux M, Sleiman C, Boczkowski J, Leseche G, Pariente R, Fournier M. Early release of proinflammatory cytokines after lung transplantation. Chest 1998, 113:645-651. 10.1378/chest.113.3.645, 9515837.
12. Maxey TS, Enelow RI, Gaston B, Kron IL, Laubach VE, Doctor A. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004, 127:541-547. 10.1016/j.jtcvs.2003.09.008, 14762366.
13. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996, 62:302-314. 10.1016/0003-4975(96)00333-5, 8678672.
14. Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 1990, 85:1150-1157. 296546, 2156895, 10.1172/JCI114547.
15. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 1992, 148:2201-2206.
16. Nolte D, Lorenzen A, Lehr HA, Zimmer FJ, Klotz KN, Messmer K. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol 1992, 346:234-237. 10.1007/BF00165307, 1448186.
17. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 1995, 27:1041-1054. 10.1016/0022-2828(95)90073-X, 7563101.
18. Murphree LJ, Sullivan GW, Marshall MA, Linden J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 2005, 391:575-580. 1276958, 16022683, 10.1042/BJ20050888.
19. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994, 76:5-13.
20. Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 2006, 176:3108-3114.
21. Day YJ, Marshall MA, Huang L, McDuffie MJ, Okusa MD, Linden J. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 2004, 286:G285-293. 10.1152/ajpgi.00348.2003, 14715520.
22. Okusa MD, Linden J, Macdonald T, Huang L. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 1999, 277:F404-412.
23. Peart J, Flood A, Linden J, Matherne GP, Headrick JP. Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol 2002, 39:117-129. 10.1097/00005344-200201000-00013, 11743234.
24. Reece TB, Okonkwo DO, Ellman PI, Warren PS, Smith RL, Hawkins AS, Linden J, Kron IL, Tribble CG, Kern JA. The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation. J Thorac Cardiovasc Surg 2004, 128:925-932.
25. Bullough DA, Magill MJ, Firestein GS, Mullane KM. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol 1995, 155:2579-2586.
26. Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, Ellman PI, Lisle TC, Kron IL. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg 2008, 135:156-165. 10.1016/j.jtcvs.2007.08.041, 18179933.
27. Ross SD, Tribble CG, Linden J, Gangemi JJ, Lanpher BC, Wang AY, Kron IL. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 1999, 18:994-1002. 10.1016/S1053-2498(99)00066-2, 10561110.
28. Sullivan GW, Linden J, Buster BL, Scheld WM. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis 1999, 180:1550-1560. 10.1086/315084, 10515815.
29. Rieger JM, Brown ML, Sullivan GW, Linden J, Macdonald TL. Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. J Med Chem 2001, 44:531-539. 10.1021/jm0003642, 11170643.
30. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001, 41:775-787. 10.1146/annurev.pharmtox.41.1.775, 11264476.
31. Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 2000, 164:436-442.
32. Lappas CM, Rieger JM, Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 2005, 174:1073-1080.
33. Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology 2005, 102:838-854. 10.1097/00000542-200504000-00021, 15791115.
34. Saito S, Ogawa J, Minamiya Y. Pulmonary reexpansion causes xanthine oxidase-induced apoptosis in rat lung. Am J Physiol Lung Cell Mol Physiol 2005, 289:L400-406. 10.1152/ajplung.00136.2005, 15879459.
35. Cassada DC, Tribble CG, Long SM, Laubach VE, Kaza AK, Linden J, Nguyen BN, Rieger JM, Fiser SM, Kron IL, et al. Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J Vasc Surg 2002, 35:994-998. 10.1067/mva.2002.123091, 12021717.
36. Reece TB, Laubach VE, Tribble CG, Maxey TS, Ellman PI, Warren PS, Schulman AM, Linden J, Kern JA, Kron IL. Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury. Ann Thorac Surg 2005, 79:1189-1195. 10.1016/j.athoracsur.2004.09.038, 15797048.
37. Rivo J, Zeira E, Galun E, Einav S, Linden J, Matot I. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock 2007, 27:266-273. 10.1097/01.shk.0000235137.13152.44, 17304107.
38. Sullivan GW. Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs 2003, 4:1313-1319.
39. Day YJ, Li Y, Rieger JM, Ramos SI, Okusa MD, Linden J. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol 2005, 174:5040-5046.
40. Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 2001, 167:4676-4685.
41. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA 1997, 94:6541-6546. 21086, 9177254, 10.1073/pnas.94.12.6541.
42. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004, 286:F298-306. 10.1152/ajprenal.00185.2003, 14600029.
43. Neely CF, Keith IM. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol 1995, 268:L1036-1046.
44. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006, 116:1913-1923. 1483170, 16823489, 10.1172/JCI27933.
45. Rivo J, Zeira E, Galun E, Matot I. Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis. Am J Transplant 2004, 4:1941-1948. 10.1111/j.1600-6143.2004.00620.x, 15575895.
46. Nakamura T, Abu-Dahab R, Menger MD, Schafer U, Vollmar B, Wada H, Lehr CM, Schafers HJ. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 2005, 24:38-45. 10.1016/j.healun.2003.10.007, 15653377.
47. Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, Verrier ED, Mulligan MS. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003, 126:200-207. 10.1016/S0022-5223(03)00390-8, 12878956.
48. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 2005, 288:F722-731. 10.1152/ajprenal.00378.2004, 15561971.
49. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, Mulligan MS. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004, 127:1502-1508. 10.1016/j.jtcvs.2003.08.019, 15116014.
50. Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003, 125:261-272. 10.1067/mtc.2003.16, 12579094.